194 participants
A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-12-13
- Start Date:
- 2021-09-18
- Completion:
- 2025-05-31
Conditions
- Advanced Neuroendocrine Carcinoma
Interventions
- DRUG
No Results Yet